NASDAQ:EDTK Inozyme Pharma Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Inozyme Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $3.02 +0.09 (+3.07 %) (As of 09/25/2020 03:45 AM ET) Add Compare Share Today's Range$2.98Now: $3.02▼$3.0350-Day Range N/A52-Week Range$2.90Now: $3.02▼$6.75Volume509 shsAverage Volume173,864 shsMarket Capitalization$36.24 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileChartCompetitorsHeadlinesSocial Media Skillful Craftsman Education Technology Limited provides vocational online education and technology services in the People's Republic of China. Its education services cover a range of subjects, including vocational, continuing, and basic education, as well as higher education. The company provides approximately 407 vocational training courses that cover a range of subjects, such as mechanics, electrical, auto repair, and construction. It operates three education platforms, including the Lifelong Education Public Service, Vocational Training, and Virtual Simulation Experimental Training platform to its fee-paying members. The company also offers technology services, including software development and maintenance, hardware installation, and testing and related consulting and training services, as well as cloud services for private companies, academic institutions, and government agencies. Skillful Craftsman Education Technology Limited was founded in 2013 and is headquartered in Wuxi, China.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Inozyme Pharma. Previous Next 0.0 Community Rank Outperform VotesInozyme Pharma has received 0 “outperform” votes. (Add your “outperform” vote.)Underperform VotesInozyme Pharma has received 0 “underperform” votes. (Add your “underperform” vote.)MarketBeat's community ratings are surveys of what our community members think about Inozyme Pharma and other stocks. Vote “Outperform” if you believe EDTK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EDTK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldInozyme Pharma does not currently pay a dividend.Dividend GrowthInozyme Pharma does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inozyme Pharma insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.00 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Educational services Sub-IndustryN/A SectorBusiness Services Current SymbolNASDAQ:EDTK Previous Symbol CUSIPN/A CIKN/A Webwww.kingwayup.com Phone8605-10-8180-5788Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees44 Outstanding Shares12,000,000Market Cap$36.24 million Next Earnings DateN/A OptionableNot Optionable $3.02 +0.09 (+3.07 %) (As of 09/25/2020 03:45 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive EDTK News and Ratings via Email Sign-up to receive the latest news and ratings for EDTK and its competitors with MarketBeat's FREE daily newsletter. Inozyme Pharma (NASDAQ:EDTK) Frequently Asked Questions Who are some of Inozyme Pharma's key competitors? Some companies that are related to Inozyme Pharma include LAIX (LAIX), Tarena International (TEDU), RYB Education (RYB), Boxlight (BOXL), Keros Therapeutics (CLEU), Ambow Education (AMBO), CIBT Education Group (MBAIF), Four Seasons Edu (Cayman) (FEDU), Zhongchao (ZCMD), BioHiTech Global (BHTG), ATA Creativity Global (AACG), ATA (ATAI), Wah Fu Education Group (WAFU), National American University Holdngs (NAUH) and Scientific Learning (SCIL). View all competitors. Who are Inozyme Pharma's key executives? Inozyme Pharma's management team includes the following people: Mr. Xiaofeng Gao, Founder, Chairman of Directors & CEO (Age 48)Mr. Jun Liu, Chief Financial Officer (Age 43)Mr. Lugang Hua, Chief Technology Officer (Age 47) When did Inozyme Pharma IPO? (EDTK) raised $15 million in an IPO on Thursday, July 23rd 2020. The company issued 3,000,000 shares at $4.50-$5.50 per share. The Benchmark Company and Axiom Capital Management, served as the underwriters for the IPO and Prime Number Capital was co-manager. What is Inozyme Pharma's stock symbol? Inozyme Pharma trades on the NASDAQ under the ticker symbol "EDTK." When did the company's quiet period expire? Inozyme Pharma's quiet period expired on Tuesday, September 1st. Inozyme Pharma had issued 3,000,000 shares in its initial public offering on July 23rd. The total size of the offering was $15,000,000 based on an initial share price of $5.00. During the company's quiet period, insiders and underwriters that worked on the IPO were restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company. How do I buy shares of Inozyme Pharma? Shares of EDTK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Inozyme Pharma's stock price today? One share of EDTK stock can currently be purchased for approximately $3.02. How big of a company is Inozyme Pharma? Inozyme Pharma has a market capitalization of $36.24 million. Inozyme Pharma employs 44 workers across the globe. What is Inozyme Pharma's official website? The official website for Inozyme Pharma is www.kingwayup.com. How can I contact Inozyme Pharma? Inozyme Pharma's mailing address is FLOOR 4 BLDG 1 NO. 311 YANXIN RD HUISHAN QU, WUXI SHI F4, 214406. The company can be reached via phone at 8605-10-8180-5788. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
